Evidence map›Paper›PMID 28608952›Full record

ArticleCancer2017

Association between patients' perception of the comorbidity burden and symptoms in outpatients with common solid tumors.

Christine S Ritchie, Fengmin Zhao, Kanan Patel, Judith Manola, Elizabeth A Kvale, Claire F Snyder, Michael J Fisch

Open access · bronzeAbstract read
In one paragraph

Article in Cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. High Symptom Burden and Low Functional Status in the Setting of Multimorbidity.Journal of the American Geriatrics Society · 2017 · on this map
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Symptom burden in patients with common cancers near end-of-life and its associations with clinical characteristics: a real-world study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  14. A COVID-19 screening tool for oncology telephone triage.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Christine S RitchieDivision of Geriatrics, Department of Medicine, University of California San Francisco, San Francisco, California.
Fengmin ZhaoDepartment of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.ORCID http://orcid.org/0000-0001-9826-3703
Kanan PatelDivision of Geriatrics, Department of Medicine, University of California San Francisco, San Francisco, California.ORCID http://orcid.org/0000-0003-3398-0116
Judith ManolaDepartment of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Elizabeth A KvaleDivision of Gerontology, Geriatrics, and Palliative Care, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Claire F SnyderDivision of General Internal Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.
Michael J FischMedical Oncology, AIM Specialty Health, Chicago, Illinois.
Dana-Farber Cancer Institute · USUniversity of California, San Francisco · USJohns Hopkins University · USRosalind Franklin University of Medicine and Science · USUniversity of Alabama at Birmingham · US

Funding

ECOG-ACRIN NCORP Research Base - TMISTUG1CA189828 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI Peter J ODwyer, MITCHELL D. SCHNALL · 2014 to 2026
$199.7M
ONCOLOGYU10CA027525 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI GOLDSTEIN, LORI J · 1985 to 2013
$6.2M
Advanced Illness and Multimorbidity (AIM) Research ProgramK07AG031779 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RITCHIE, CHRISTINE S · 2008 to 2012
$540k
NCI NIH HHS U10 CA027525NCI NIH HHS UG1 CA189828NIA NIH HHS K07 AG031779
6 · The paper itself

Abstract

backgroundCancer patients' symptom burden is commonly attributed to their cancer and treatment. Increasingly, cancer patients have many other chronic comorbid conditions. However, the degree to which these comorbid conditions may contribute to the patient-reported symptom burden is unclear.

methodsThis study explored the relations between the presence of comorbid conditions, the symptom experience and burden, and the perceived bother from cancer or comorbid conditions in 3106 cancer patients. The associations between the number of comorbidities (identified from current medications), the patient-reported symptom burden (the number of symptoms scored as ≥7 on the 13-item MD Anderson Symptom Inventory physical scale), the patient-reported bother from comorbid conditions and from cancer (from "not at all" to "extremely"), and the clinician-reported difficulty in caring for patients' symptoms were examined.

resultsAccording to medication lists, 19% of the patients had at least 5 of 12 comorbid conditions. Approximately 39% rated at least 1 symptom as ≥ 7, and this proportion increased with an increasing number of comorbid conditions (48% with ≥ 5 comorbid conditions vs 36% with 1 comorbid condition). One-third of the patients reported moderate or worse bother, and this was significantly associated with an increased number of comorbid conditions (odds ratio [OR], 2.4) and an increased symptom burden (OR, 1.22). Clinician ratings of difficulty in managing patients' symptoms were significantly associated with bother from cancer (OR, 2.0), comorbid conditions (OR, 1.6), and symptom burden (OR, 1.1).

conclusionsComorbidity is common in cancer patients and is associated with a greater symptom burden and clinician reports of difficulty in managing patients' symptoms. Greater attention to comorbid conditions is needed to optimize the symptom management of cancer patients with multimorbidity. Cancer 2017;123:3835-3842. © 2017 American Cancer Society.

Indexed as

Pharmaceutical PreparationsSymptom AssessmentAdultAgedAged, 80 and overChronic DiseaseComorbidityFemaleHumansMaleMiddle AgedNeoplasmsOdds RatioPerceptionUnited StatesPharmaceutical Preparationscancercomorbidityoutpatient cancer patients with solid tumorssymptom burdenSymptom Outcomes and Practice Patterns (SOAPP) study

Identifiers

PMID28608952
PMCPMC5610613
OpenAlexW2625565057

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.